Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	309.39B +53.9%
Revenue (ttm)	15.20B +83.7%
Net Income	273.36M
EPS	11.00
Shares Out	25.80M
PE Ratio	1,131.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	395,414
Average Volume	185,115
Open	11,250
Previous Close	11,100
Day's Range	10,860 - 12,090
52-Week Range	7,130 - 13,450
Beta	0.07
RSI	55.40
Earnings Date	May 15, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820